In addition, given the transmembrane location of IFITM5 it may be a potential therapeutic target for other bone disorders such as fibrodysplasia ossificans progressiva and other forms of ectopic ossification. This evidence concerns the gene IFITM5 and fibrodysplasia ossificans progressiva.